The Thyroid Pharmacist

JUNE 30, 2023

You may be familiar with naltrexone, which is an FDA-approved medication that has been used since the 1980s for opioid withdrawal. The first article was published in 2007, and it showed LDN as an effective and safe therapy for Crohn’s disease. [4] It needs to be compounded into lower doses by a professional compounding pharmacy.

Compounding 98

Compounding Immunization Compounding Pharmacies Adverse Reactions 98

ISPE

MARCH 8, 2023

Identification and Analysis of Contamination Trends Three major recall databases—those of the US FDA, the United Kingdom’s Medicine and Healthcare Products Regulatory Agency (UK MHRA), and Australia’s Therapeutic Goods Administration (TGA)—were searched to assess contamination trends in the past five years.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

The Thyroid Pharmacist

NOVEMBER 15, 2024

17] Ozempic is a once-weekly injection that was approved by the FDA in 2017 for use in adults with type 2 diabetes. Compounding pharmacies will sometimes repackage these drugs, or create lower or different concentrations than what’s typically available. 2007 Mar;2(2):366-73. Ozempic is not approved for weight loss.

Immunization 75

Immunization Compounding Compounding Pharmacies Labelling 75